クオリプスの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2024/09/11 | 7,580 | 7,670 | 7,230 | 7,340 | -120 | -1.6% | 175,500 |
| 2024/09/10 | 7,540 | 7,590 | 7,310 | 7,460 | -80 | -1.1% | 140,900 |
| 2024/09/09 | 7,000 | 7,560 | 6,990 | 7,540 | +250 | +3.4% | 188,100 |
| 2024/09/06 | 7,330 | 7,400 | 7,080 | 7,290 | -10 | -0.1% | 185,800 |
| 2024/09/05 | 7,440 | 7,530 | 7,230 | 7,300 | -180 | -2.4% | 232,900 |
| 2024/09/04 | 7,520 | 7,790 | 7,470 | 7,480 | -300 | -3.9% | 271,100 |
| 2024/09/03 | 7,980 | 8,280 | 7,710 | 7,780 | -200 | -2.5% | 465,300 |
| 2024/09/02 | 8,180 | 8,390 | 7,900 | 7,980 | -160 | -2% | 457,200 |
| 2024/08/30 | 7,730 | 8,200 | 7,620 | 8,140 | +680 | +9.1% | 813,000 |
| 2024/08/29 | 7,500 | 7,580 | 7,250 | 7,460 | +40 | +0.5% | 286,100 |
| 2024/08/28 | 7,550 | 8,040 | 7,310 | 7,420 | -140 | -1.9% | 737,700 |
| 2024/08/27 | 6,980 | 7,640 | 6,830 | 7,560 | +580 | +8.3% | 497,400 |
| 2024/08/26 | 7,100 | 7,310 | 6,960 | 6,980 | -50 | -0.7% | 190,100 |
| 2024/08/23 | 6,940 | 7,120 | 6,920 | 7,030 | +90 | +1.3% | 177,600 |
| 2024/08/22 | 7,130 | 7,220 | 6,870 | 6,940 | -200 | -2.8% | 209,800 |
| 2024/08/21 | 7,180 | 7,460 | 7,020 | 7,140 | -50 | -0.7% | 237,500 |
| 2024/08/20 | 7,610 | 7,710 | 7,070 | 7,190 | -410 | -5.4% | 781,400 |
| 2024/08/19 | 6,760 | 7,600 | 6,750 | 7,600 | +1,000 | +15.2% | 604,800 |
| 2024/08/16 | 7,300 | 7,320 | 6,550 | 6,600 | -80 | -1.2% | 459,600 |
| 2024/08/15 | 6,340 | 6,880 | 6,280 | 6,680 | +440 | +7.1% | 354,100 |
| 2024/08/14 | 6,610 | 6,670 | 6,200 | 6,240 | -650 | -9.4% | 411,500 |
| 2024/08/13 | 6,510 | 6,970 | 6,450 | 6,890 | +550 | +8.7% | 196,000 |
| 2024/08/09 | 6,420 | 6,500 | 6,150 | 6,340 | -70 | -1.1% | 250,200 |
| 2024/08/08 | 6,350 | 6,500 | 6,260 | 6,410 | +120 | +1.9% | 147,200 |
| 2024/08/07 | 6,080 | 6,580 | 6,030 | 6,290 | +150 | +2.4% | 282,400 |
| 2024/08/06 | 6,000 | 6,350 | 5,890 | 6,140 | +760 | +14.1% | 372,400 |
| 2024/08/05 | 6,230 | 6,540 | 5,380 | 5,380 | -1,000 | -15.7% | 534,300 |
| 2024/08/02 | 6,000 | 6,750 | 6,000 | 6,380 | -120 | -1.8% | 359,300 |
| 2024/08/01 | 6,470 | 6,580 | 6,040 | 6,500 | -210 | -3.1% | 380,000 |
| 2024/07/31 | 7,000 | 7,090 | 6,610 | 6,710 | -400 | -5.6% | 322,300 |
| 2024/07/30 | 7,300 | 7,300 | 7,040 | 7,110 | -100 | -1.4% | 118,800 |
| 2024/07/29 | 7,250 | 7,400 | 7,160 | 7,210 | -110 | -1.5% | 156,000 |
| 2024/07/26 | 7,180 | 7,340 | 7,120 | 7,320 | +240 | +3.4% | 142,700 |
| 2024/07/25 | 7,000 | 7,280 | 6,980 | 7,080 | -130 | -1.8% | 165,500 |
| 2024/07/24 | 7,370 | 7,540 | 7,180 | 7,210 | -160 | -2.2% | 236,200 |
| 2024/07/23 | 7,490 | 7,690 | 7,350 | 7,370 | -30 | -0.4% | 185,000 |
| 2024/07/22 | 7,530 | 7,890 | 7,340 | 7,400 | -100 | -1.3% | 314,300 |
| 2024/07/19 | 8,050 | 8,100 | 7,300 | 7,500 | -600 | -7.4% | 426,700 |
| 2024/07/18 | 7,530 | 8,200 | 7,500 | 8,100 | +440 | +5.7% | 437,400 |
| 2024/07/17 | 8,010 | 8,140 | 7,620 | 7,660 | -320 | -4% | 478,200 |
| 2024/07/16 | 7,920 | 8,090 | 7,710 | 7,980 | +180 | +2.3% | 483,200 |
| 2024/07/12 | 7,280 | 7,940 | 7,210 | 7,800 | +670 | +9.4% | 1,028,100 |
| 2024/07/11 | 7,390 | 7,480 | 6,950 | 7,130 | -300 | -4% | 273,000 |
| 2024/07/10 | 7,210 | 7,500 | 7,180 | 7,430 | +170 | +2.3% | 283,600 |
| 2024/07/09 | 7,340 | 7,620 | 7,180 | 7,260 | -170 | -2.3% | 198,400 |
| 2024/07/08 | 7,720 | 7,780 | 7,430 | 7,430 | -420 | -5.4% | 312,700 |
| 2024/07/05 | 7,490 | 7,850 | 7,460 | 7,850 | +510 | +6.9% | 377,000 |
| 2024/07/04 | 7,280 | 7,360 | 7,010 | 7,340 | +190 | +2.7% | 244,500 |
| 2024/07/03 | 6,950 | 7,200 | 6,890 | 7,150 | +150 | +2.1% | 142,900 |
| 2024/07/02 | 7,000 | 7,240 | 6,870 | 7,000 | -30 | -0.4% | 252,600 |
201～
250
件表示中 / 499件
類似銘柄と比較する
現在ご覧いただいている「クオリプス」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| クオリプス | 608,000円 | +237.1% | - | 0.00% | - | 8.93倍 |
|
大阪大学発ベンチャー。ｉＰＳ細胞由来のシートによる世界初の重症心不全治療法開発に注力 |
| タウンズ | 53,200円 | +4.6% | +6.1% | 5.26% | 9.07倍 | 3.35倍 |
|
院内で行う迅速抗原検査の体外診断薬専業大手。新型コロナ、インフルなど呼吸器感染症首位 |
| ヘリオス | 54,400円 | +150.0% | - | 0.00% | - | 27.60倍 |
|
ｉＰＳ細胞、体性幹細胞を活用する再生医薬品バイオベンチャー。住友ファーマと共同開発も |
| 生化学 | 61,600円 | -9.6% | -30.2% | 4.87% | 24.90倍 | 0.46倍 |
|
複合糖質で独自性。開発は関節疾患関連に特化。２種のヒアルロン酸製剤は科研と参天が販売 |
| 富士製薬 | 132,700円 | +15.7% | +5.3% | 3.43% | 9.59倍 | 0.71倍 |
|
女性医療、急性期医療の２領域に強い後発薬メーカー。注射剤が主体。新薬・バイオ後続品も |
市場注目の銘柄
チャート関連のコラム
